Emcure Pharmaceuticals Ltd Board of Directors
Board of Directors at Emcure Pharmaceuticals Ltd
Chairman & Independent Directo
Company Sec. & Compli. Officer
Whole Time Director
Whole Time Director
Independent Director
Key Highlights
- MUKUND KESHAO GURJAR continues to serve as the Whole Time Director in 2025, maintaining the same position as in the previous year.
- SATISH RAMANLAL MEHTA joins the board as CMD & CEO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- NAMITA VIKAS THAPAR joins the board as Whole-time Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- SAMIT SATISH MEHTA joins the board as Whole Time Director & COO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vidya Rajiv Yeravdekar joins the board as Independent Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Emcure Pharmaceuticals Ltd
NSE: EMCURE
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 29 Sep 2026 | 1959.7 |
| 28 Sep 2026 | 1925.75 |
| 25 Sep 2026 | 1945.15 |
| 24 Sep 2026 | 1952.7 |
| 23 Sep 2026 | 1981.15 |
| 22 Sep 2026 | 1975.55 |
| 21 Sep 2026 | 2000.8 |
| 18 Sep 2026 | 2015.75 |
| 17 Sep 2026 | 1910.1 |
| 16 Sep 2026 | 1932.25 |
Company Fundamentals for Emcure Pharmaceuticals Ltd
Market Cap
37,177 Cr
EPS
54.3
P/E Ratio (TTM)
36.1
P/B Ratio (TTM)
7.5
Day’s High
1963.7
Day’s Low
1906.4
DTE
0.3
ROE
18.7
52 Week High
2101.0
52 Week Low
1260.1
ROCE
21.8
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Emcure Pharmaceuticals Ltd News Hub
Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 24
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 24
Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Emcure Pharmaceuticals to declare Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 24
